jimmy Turano

Four Biotech Stocks to Play the Sector Pullback

VFC-I am surprised you didn't include CELEGENE.
I AM NOT SURPRISED THAT YOU LEFT OUT 'MRNA'.
Which I have been requesting you to elaborate on for
the weary shareholders.
But VFC I think after this years turmoil on the stock market, economy, and many getting burnt financially already, it maybe time
for you to take a vacation. Regenerate, physically & mentally and
come back in January 2010 with a new attitude on investing.
Starting with you wearing a pinstripe suit,blue shirt, and red tie,
but sitting behind an oak desk, looking like a successful adviser
to the general public.
TIME TO WAKE UP VFC!

Biotech Sector Pullback: Good Time to Buy at a Discount

Wed.10/28/09 vfc now while the stock market is anemic,
with compounding bad news from many sectors, I totally disagree to bargain hunt now at all. The market still may take a hit, but even so the recovery if an is years away.
Look at 'MRNA' Today closed at $1.02, and two weeks ago I asked you to discuss the stock, when it was $1.46.
I thought it would be headed under $1 dollar again, and now with barchart giving short,medium,long trend indicators of 100% sell with overall average of 100% sell,
it's TIMBER for this one.
Your new photo soon won't be sitting in a hammock long,
rather most probale postion will on the ground, because the Market is more than set for Clean out of sorts.
This is not a time to bargain hunt, but a time to hold onto your money with both fists.

Cell Therapeutics Could Be a Real Winner, But Not Right Now

YOUR HONESTY IS REFRESHING.
Too many research firms& their high target prices for years have mislead investors on biotech stocks.
Your article title: Cell Therapeutics Could Be a Real Winner, But Not Right Now
could also apply to 'MRNA' for sure, No serious Revenue,pre-clinical stage company, lots of hype day in day out, more like a channeling stock for years, and lastly in my opinion way overvalued,
What is your perspective on 'MRNA'?

Extreme FDA Trades: 30 Stocks Under 5 Bucks

Nice article Mike. But you left out one of the best channeling stocks
on the market for 5 years straight. "MRNA'
PIPE DREAMS, OF STRIKING IT RICH, IS ON SHAREHOLDERS MINDS.
BUT THE CHANNELING EXPERTS MANIPULATE THIS STOCK SO MUCH THEY ALWAYS TURN A PROFIT LEAVING THE LONG INVESTORS BEWILDERED EACH TIME.

Biggest Health Care Winners Become Biggest Losers After Friday's Market Action

MR.GARZA,
Please give your perspective on 'MRNA'
As I predicted when the stock was $10.21, ON THE MOTELY FOOL CAPS SITE, and the fact that the stock then hit $.14 cents,
two years later, speaks louder than words.
HOWS THAT FOR FORECASTING, MR.GARZA?
So this year 'MRNA' rallied to $1.99 on news of two partnerships, nd pure hype, creating an overbought, overpriced stock, that has now retreated to $1.42. I still believe
it is overpriced at this level and the trend is now bearish.
The only sad part for me, was that everyone at the SEC overlooked the fact that during all of 2007, the insiders were selling the most shares ever. And as we all know today, at the end of 2007, P&G broke up their partnership with then NSTK.
Does anyone believe that that was purely a coincidence by insiders? The SEC is to be shareholders advocates, but with all the corruption that unfolded since September 08 to present, it appears that the SEC
looked the other way.
CARE TO STEP UP TO THE PLATE MR.GARZA AND BE HEARD?